Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Spiers

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 19, 2022
Effects of human tissue acoustic properties, abdominal wall shape, and respiratory motion on ultrasound-mediated hyperthermia for targeted drug delivery to pancreatic tumorsMichael Gray, Laura Spiers, Constantin Coussios
Rheumatology (Oxford, England)|December 10, 2019
Toxicities associated with checkpoint inhibitors-an overviewLaura Spiers, Nicholas Coupe, Miranda Payne
Medical Physics|July 21, 2023
Sound speed and attenuation of human pancreas and pancreatic tumors and their influence on focused ultrasound thermal and mechanical therapiesMichael D Gray, Laura Spiers, Constantin C Coussios
BMJ Quality Improvement Reports|January 7, 2016
Recognition of the deteriorating patientLaura Spiers, Jagdeep Singh Mohal, Jonathan Pearson-Stuttard, et al.
BMC Cancer|September 23, 2023
Clinical trial protocol for PanDox: a phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin (ThermoDox®) and focused ultrasoundLaura Spiers, Michael Gray, Paul Lyon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2021
A Phase Ib Open-Label, Dose-Escalation Study of NUC-1031 in Combination with Carboplatin for Recurrent Ovarian CancerFarasat Kazmi, Shibani Nicum, Rene L Roux, et al.
Journal for Immunotherapy of Cancer|October 9, 2020
Impact of age on the toxicity of immune checkpoint inhibitionAmit Samani, Shuai Zhang, Laura Spiers, et al.
EMBO Molecular Medicine|June 22, 2017
Oncolytic adenovirus expressing bispecific antibody targets T-cell cytotoxicity in cancer biopsiesJoshua D Freedman, Joachim Hagel, Eleanor M Scott, et al.
Investigational New Drugs|May 2, 2026
Hedgehog Inhibitor and Paclitaxel: A Phase I Trial of the Oral Hedgehog inhibitor Taladegib in Combination with Weekly Paclitaxel in Patients with Advanced Solid TumoursRosalind Glasspool, Sarah Patricia Blagden, Michelle Lockley, et al.
British Journal of Cancer|September 13, 2018
Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I studySarah P Blagden, Ivana Rizzuto, Puvan Suppiah, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 19, 2022
Effects of human tissue acoustic properties, abdominal wall shape, and respiratory motion on ultrasound-mediated hyperthermia for targeted drug delivery to pancreatic tumorsMichael Gray, Laura Spiers, Constantin Coussios
Rheumatology (Oxford, England)|December 10, 2019
Toxicities associated with checkpoint inhibitors-an overviewLaura Spiers, Nicholas Coupe, Miranda Payne
Medical Physics|July 21, 2023
Sound speed and attenuation of human pancreas and pancreatic tumors and their influence on focused ultrasound thermal and mechanical therapiesMichael D Gray, Laura Spiers, Constantin C Coussios
BMJ Quality Improvement Reports|January 7, 2016
Recognition of the deteriorating patientLaura Spiers, Jagdeep Singh Mohal, Jonathan Pearson-Stuttard, et al.
BMC Cancer|September 23, 2023
Clinical trial protocol for PanDox: a phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin (ThermoDox®) and focused ultrasoundLaura Spiers, Michael Gray, Paul Lyon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2021
A Phase Ib Open-Label, Dose-Escalation Study of NUC-1031 in Combination with Carboplatin for Recurrent Ovarian CancerFarasat Kazmi, Shibani Nicum, Rene L Roux, et al.
Journal for Immunotherapy of Cancer|October 9, 2020
Impact of age on the toxicity of immune checkpoint inhibitionAmit Samani, Shuai Zhang, Laura Spiers, et al.
EMBO Molecular Medicine|June 22, 2017
Oncolytic adenovirus expressing bispecific antibody targets T-cell cytotoxicity in cancer biopsiesJoshua D Freedman, Joachim Hagel, Eleanor M Scott, et al.
Investigational New Drugs|May 2, 2026
Hedgehog Inhibitor and Paclitaxel: A Phase I Trial of the Oral Hedgehog inhibitor Taladegib in Combination with Weekly Paclitaxel in Patients with Advanced Solid TumoursRosalind Glasspool, Sarah Patricia Blagden, Michelle Lockley, et al.
British Journal of Cancer|September 13, 2018
Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I studySarah P Blagden, Ivana Rizzuto, Puvan Suppiah, et al.
Pageof 2